| Product Name | Ruplizumab (Synonyms: BG 9588; Anti-Human CD40L Recombinant Antibody) |
|---|---|
| CAS | 220651-94-5 |
| Storage condition | Sealed and stored at ≤-20℃, away from light. Avoid freeze-thaw cycles |
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
|---|---|---|---|---|
| 1 mg | 3-5days | ¥3200.00 | Visible after login | |
| 5 mg | 3-5days | ¥15800.00 | Visible after login | |
| 10 mg | 3-5days | ¥28600.00 | Visible after login | |
| 50 mg | 3-5days | ¥128000.00 | Visible after login | |
| 100 mg | 3-5days | ¥236000.00 | Visible after login |
| Product Name | Ruplizumab (Synonyms: BG 9588; Anti-Human CD40L Recombinant Antibody) |
|---|---|
| CAS | 220651-94-5 |
| Storage condition | Sealed and stored at ≤-20℃, away from light. Avoid freeze-thaw cycles |
Ruplizumab (Anti-TNFSF5 / CD40L / CD154) is a humanized monoclonal antibody targeting CD40L(TNF Receptor). It has the potential for systemic lupus erythematosus disease research. MW :145.68 KD.